abstract |
The present invention relates to compounds of formula (I), their use as inhibitors of microsomal prostaglandin E 2 synthase-1 (mPGES-1), pharmaceutical compositions containing them, and inflammatory diseases and It relates to their use as a medicament for the treatment and / or prevention of associated conditions. A, M, W, R 1 , R 2 , R 6 , R 7 , R 8 have the meanings given herein. |